№ lp_2_3_29672
File format: docx
Character count: 5476
File size: 1517 KB
Year:
2019
Region / City:
Colorado, Wyoming
Topic:
Organ, eye, and tissue donation
Document Type:
Informational factsheet
Organization:
Donate Life Colorado, Donate Life Wyoming
Author:
Not specified
Target Audience:
General public
Effective Date:
Not specified
Date of Approval:
Not specified
Date of Changes:
Not specified
Context:
An informational document providing statistics and key facts about organ, eye, and tissue donation, including how to register and the impact of donation.
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Confidential – Multi-Agency Risk Assessment Conference (MARAC) Domestic Abuse Risk Assessment (DASH)
Note:
Year
Personal Information – Commercial Client Agreement(Suggested Language for IBC DASH – 30th June 2023)
Note:
Date
Year:
2023
Subject:
Personal Information, Insurance Policy, Underwriting Purposes, Analytics Purposes
Document Type:
Agreement
Target Audience:
Clients, Insurance Brokers
Safe in Salford: Harbour Project Referral Form and Young People’s DASH Risk Identification Checklist
Organisation:
Safe in Salford – Harbour Project
Service Area:
Salford
Contact Email:
[email protected]
Document Type:
Referral form and risk assessment checklist
Target Group:
Children and Young People aged 0–18 (up to 21 for specific programmes)
Associated Services:
TDAS (Trafford Domestic Abuse Services); TLC Talk Listen Change Services
Programmes Included:
Early Years Support (0–5); R’Space (5–14); 1-2-1 (5–11); 1-2-1 12+ (12–21); Children and Family Support (5–11); Counselling (5–18); Young Person Who Harms (10–21); Respect Young People’s Programme (10–21)
Risk Assessment Tool:
SafeLives Young People’s DASH Risk Identification Checklist (13–17)
Subject:
Domestic abuse, harmful behaviour, safeguarding
Required Information:
Personal details, consent confirmation, agency involvement, safeguarding concerns, risk indicators
Intended Users:
Referring professionals and agencies
Geographical Scope:
Salford and Trafford
Year:
2021
Date:
January 4, 2021
OMB Number:
0920-0840
Expiration Date:
01/01/2022
Program:
DASH DEMO – Comprehensive Health Educator Core Knowledge and Skills (CHECKS) Professional Development Pilot Study
Section:
Supporting Statement Part B – Collection of Information Employing Statistical Methods
Organization:
Division of Adolescents and School Health, NCHHSTP, Centers for Disease Control and Prevention
Project Officer:
Natalie Wilkins
Project Officer Title:
Behavioral Scientist
Implementing Organization:
ICF
Participating Institution:
Portland Public Schools
Location:
Atlanta, GA; Portland, OR
Study Population:
Middle and high school health teachers and their students
Sample Size:
Up to 50 teachers and up to 1,750 students
Academic Year:
2021–2022
Type of Document:
Federal supporting statement for data collection under OMB clearance
Data Collection Methods:
Web-based surveys, pre/post measurement tools, training feedback surveys
IRB Approval Date:
12/21/2020
Data Systems:
Inquisiq LMS; SurveyMonkey
Subject Area:
Health education professional development and instructional competencies
Year:
2026
Region:
Cambridgeshire and Peterborough, UK
Document Type:
Risk Assessment Form
Agency:
Multi-Agency Risk Assessment Conference (MARAC)
Author:
IDVA Services
Target Audience:
Professionals making domestic abuse referrals
Applicable Period:
Current
Consent Requirement:
Preferable but not essential
Referral Threshold:
17 ticks or above for MARAC, 14–16 ticks for IDVA Service with consent
Specialist Services Included:
Young People, Minority Ethnic, Eastern European, Older People, Housing Link IDVAs
Submission Method:
Online referral form required, handwritten forms not accepted
Date Completed:
As indicated by user
Client Information:
Name, Date of Birth, Current Situation, Children/Dependents
Risk Factors:
Injury, fear, isolation, depression, separation, child contact conflict, stalking, prior abuse, violence history, use of weapons, sexual abuse, threats, animal mistreatment
Date:
1st June 2025
Venue:
ASV swimming pool
Type of event:
Swimming competition
Club Registration:
SASA registered
Payment details:
BACS transfer, Sort Code: 80 05 14, Account No: 0010494383
Event Date:
1st June 2025
Location:
ASV Swimming Pool
Competitors:
Must be SASA registered
Age Group:
Not specified
Entry Fee:
£6.50 per male and female entry, £8.00 per relay entry
Closing Date for Entries:
30th April 2025
Year:
2025
Jurisdiction:
Namibia, Windhoek
Case number:
HC-MD-CIV-MOT-GEN-2024/00102
Court:
High Court of Namibia, Main Division
Parties:
Bank Windhoek Limited (Applicant), Dash Enterprises Number One CC, Limbo Investment CC, John Dalton Hashondali Ashikoto (Respondents)
Legal issue:
Application to declare immovable property specially executable
Property:
Section 25, Henning Village, Erf 317, Kleine Kuppe, Windhoek
Deed of Transfer:
ST930/2018
Settlement agreements:
25 October 2022, 25 October 2025, 8 November 2025
Judgment delivered:
15 August 2025
Hearing date:
16 July 2025
Citation:
[2025] NAHCMD 462
Outcome:
Application granted; property declared specially executable; costs on party-party scale
Year:
2023
Region / City:
United States
Topic:
Blood Donation Eligibility
Document Type:
Eligibility Guidelines
Organization / Institution:
U.S. Food and Drug Administration (FDA)
Author:
U.S. Food and Drug Administration
Target Audience:
Blood Donors, Medical Professionals, Blood Banks
Effective Period:
Ongoing
Approval Date:
May 2023
Date of Changes:
December 2007, May 2023
Year:
2021
Region / City:
Australia
Topic:
Biologicals, Human Cell and Tissue Products, Donor Screening
Document Type:
Guideline
Agency:
Therapeutic Goods Administration (TGA)
Author:
Therapeutic Goods Administration (TGA)
Target Audience:
Manufacturers and Sponsors of Biological Products
Effective Period:
2021
Approval Date:
May 2021
Amendment Date:
N/A
Note:
Year
Year:
2025
Region / City:
Quetta, Balochistan
Subject:
Procurement of vehicle rental services
Document Type:
Bidding Document
Organization:
People’s Primary Healthcare Initiative (PPHI) - Balochistan
Author:
People’s Primary Healthcare Initiative (PPHI) - Balochistan
Target Audience:
Bidders, Contractors, Firms, Individuals
Effective Period:
Until June 2026
Approval Date:
__________________
Amendment Date:
__________________
Year:
202-
Region / City:
London
Theme:
Neurological Disorders, Research, Human Tissue
Document Type:
Agreement
Organization / Institution:
University College London
Author:
Not specified
Target Audience:
Researchers, UCL Faculty
Period of Validity:
Until expiration date
Approval Date:
2025-06-02
Amendment Date:
Not specified
Context:
This is a Material Transfer Agreement (MTA) for the provision of human tissue samples and related donor information to a recipient for research purposes at University College London.
Year:
2018
Region / city:
United States
Topic:
Medical history screening for blood donation
Document type:
Questionnaire
Organization:
U.S. Department of Health and Human Services
Author:
Unknown
Target audience:
Blood donors
Period of validity:
Ongoing
Approval date:
May 2018
Amendment date:
None
Year:
N/A
Region / City:
N/A
Subject:
Donor eligibility for cord blood donation
Document Type:
Eligibility Questionnaire
Organization / Institution:
N/A
Author:
N/A
Target Audience:
Individuals interested in donating cord blood
Validity Period:
N/A
Approval Date:
N/A
Amendment Date:
N/A
Year:
2004
Region / City:
USA
Topic:
Health regulations, Donor eligibility
Document type:
Regulatory guidance
Organization / Institution:
U.S. Department of Health and Human Services, Food and Drug Administration
Author:
U.S. Department of Health and Human Services, Food and Drug Administration
Target audience:
Healthcare professionals, tissue product manufacturers
Period of validity:
N/A
Approval date:
May 25, 2004
Date of changes:
N/A
Context:
Regulatory guidelines and FDA documentation related to the eligibility criteria for donors of human cells, tissues, and cellular products.
Year:
Not specified
Region / City:
Not specified
Topic:
Hematopoietic progenitor cell (HPC) donor screening
Document Type:
User instructions / Guidelines
Organization / Institution:
Interorganizational Uniform Donor History – HPC Task Force
Author:
Not specified
Target Audience:
Healthcare providers involved in donor screening
Validity Period:
Not specified
Approval Date:
Not specified
Date of Amendments:
Not specified
Year:
May 2018
Region / city:
United States
Topic:
Donor Screening, Medical History
Document Type:
Questionnaire
Author:
Not specified
Target Audience:
Potential organ and tissue donors
Duration:
Ongoing, no specific expiration date mentioned
Approval Date:
May 2018
Date of Changes:
Not mentioned
Additional Notes:
Includes questions on Zika virus, HIV, hepatitis, malaria, and other conditions
Context:
A medical questionnaire used to assess the eligibility of individuals for donating human cells, tissues, and related products.
Document type:
Educational information sheet
Subject:
Donor eligibility and infectious disease risk
Medical focus:
Stem cell and bone marrow donation
Primary topics:
Donor screening, sexual contact definitions, HIV/AIDS risk factors
Intended audience:
Prospective donors
Confidentiality:
Donor information treated as confidential
Health conditions referenced:
HIV, AIDS, syphilis, gonorrhea
Risk factors addressed:
Sexual contact, drug injection, incarceration, travel or residence abroad
Timeframes referenced:
Past 5 years, past 12 months
Issuing entity:
Donor center
Source category:
Medical donor guidance
Year:
2017
Topic:
Blood donation eligibility
Document type:
Donor screening guidance
Disease focus:
Ebola virus disease
Issuing authority:
U.S. Food and Drug Administration
Referenced authority:
Centers for Disease Control and Prevention
Target audience:
Blood collection establishments
Geographic scope:
Countries with Ebola virus transmission
Deferral period:
Indefinite or 8 weeks depending on exposure
Regulatory references:
21 CFR 630.10(e)(2) and (h)
Guidance date:
January 2017
Content basis:
Epidemiologic risk assessment and exposure history